{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:06:56Z","timestamp":1695730016812},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,7,15]],"date-time":"2005-07-15T00:00:00Z","timestamp":1121385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s00405-005-0988-0","type":"journal-article","created":{"date-parts":[[2005,7,14]],"date-time":"2005-07-14T10:24:51Z","timestamp":1121336691000},"page":"271-275","source":"Crossref","is-referenced-by-count":9,"title":["Intratympanic gentamicin in monolateral Meniere\u2019s disease: our experience"],"prefix":"10.1007","volume":"263","author":[{"given":"Giulia","family":"Bertino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Durso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Manfrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Casati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Mira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,7,15]]},"reference":[{"key":"988_CR1","first-page":"125","volume":"Rhinol","author":"Aran","year":"1993","unstructured":"Aran JM, Dulon D, Hiel H, Erre JP, Aurousseau C (1993) L\u2019ototoxicit\u00e9 d\u2019aminoglicosides: r\u00e9sultats r\u00e9cents sur la captation et la clairance de la gentamicine par les cellules sensorielles du limacon osseux. Rev Laryngol Otol Rhinol (Bord) 114:125\u2013128","journal-title":"Rev Laryngol Otol"},{"key":"988_CR2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0196-0709(99)90011-X","volume":"20","author":"Atlas","year":"1999","unstructured":"Atlas JT, Parnes LS (1999) Intratympanic gentamicin titration therapy for intractable Meniere\u2019s disease. Am J Otol 20:257\u2013263","journal-title":"Am J Otol"},{"key":"988_CR3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00455886","volume":"221","author":"Beck","year":"1978","unstructured":"Beck C, Schimdt CL (1978) Ten years experience with intratympanically applied streptomycin (gentamicin) in the therapy of morbus Meniere. Arch Otorhinolaryngol 221:149\u2013152","journal-title":"Arch Otorhinolaryngol"},{"key":"988_CR4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00129492-200407000-00025","volume":"25","author":"Black","year":"2004","unstructured":"Black FO, Pesznecker S, Stallings V (2004) Permanent gentamicin vestibulotoxicity. Otol Neurotol 25:559\u2013569","journal-title":"Otol Neurotol"},{"key":"988_CR5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00005537-200002010-00009","volume":"110","author":"Blakley","year":"2000","unstructured":"Blakley BW (2000) Update of intratympanic gentamicin for Meniere\u2019s disease. Laryngoscope 110:236\u2013240","journal-title":"Laryngoscope"},{"key":"988_CR6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00129492-200407000-00023","volume":"25","author":"Chia","year":"2004","unstructured":"Chia SH, Gamst AC, Anderson JP, Harris JP (2004) Intratympanic gentamicin therapy for Meniere\u2019s disease: a meta-analysis. Otol Neurotol 25:544\u2013552","journal-title":"Otol Neurotol"},{"key":"988_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0194-5998(95)70102-8","volume":"113","author":"Committee","year":"1995","unstructured":"Committee on Hearing and Equilibrium of the American Academy of Otolaryngology Head and Neck Surgery (1995) Committee on hearing and equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere\u2019s disease. Otolaryngol Head Neck Surg 113:181\u2013185","journal-title":"Otolaryngol Head Neck Surg"},{"key":"988_CR8","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/00005537-199911000-00014","volume":"109","author":"Conlon","year":"1999","unstructured":"Conlon BJ, Gibson PR (1999) Meniere\u2019s disease: the incidence of hydrops in the controlateral asymptomatic ear. Laryngoscope 109:1800\u20131802","journal-title":"Laryngoscope"},{"key":"988_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00005537-199701000-00017","volume":"107","author":"Driscoll","year":"1997","unstructured":"Driscoll CLW, Kasperbauer JL, Facer GW, Harner SG (1997) Low-dose intratympanic gentamicin and the treatment of Meniere\u2019s disease: preliminary results. Laryngoscope 107:83\u201389","journal-title":"Laryngoscope"},{"key":"988_CR10","first-page":"239","volume":"52","author":"Fowler","year":"1948","unstructured":"Fowler E (1948) Streptomycin treatment of vertigo. Trans Am Acad Ophtalmol Otolaryngol 52:239\u2013301","journal-title":"Trans Am Acad Ophtalmol Otolaryngol"},{"key":"988_CR11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00129492-200103000-00016","volume":"22","author":"Harner","year":"2001","unstructured":"Harner SG, Driscoll CLW, Facer GW, Beatty CW, McDonald TJ (2001) Long-term follow-up of transtympanic gentamicin for Meni\u00e8re\u2019s syndrome. Otol Neurotol 22:210\u2013214","journal-title":"Otol Neurotol"},{"key":"988_CR12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0196-0709(97)90069-7","volume":"18","author":"Hirsch","year":"1997","unstructured":"Hirsch BE, Kamerer DB (1997) Intratympanic gentamicin therapy for Meniere\u2019s disease. Am J Otol 18:44\u201351","journal-title":"Am J Otol"},{"key":"988_CR13","first-page":"296","volume":"41","author":"Hoffman","year":"1993","unstructured":"Hoffman F, Beck, C Beck C, Stratulat S (1993) Subablative gentamicin therapy in Meniere\u2019s disease. HNO 41:296\u2013300","journal-title":"HNO"},{"key":"988_CR14","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/00005537-200008000-00014","volume":"110","author":"Kaplan","year":"2000","unstructured":"Kaplan DM, Nedzelski JM, Chen JM, Shipp DB (2000) Intratympanic gentamicin for the treatment of unilateral Meniere\u2019s disease. Laryngoscope 110:1298\u20131305","journal-title":"Laryngoscope"},{"key":"988_CR15","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1288\/00005537-198110000-00014","volume":"91","author":"Kumar","year":"1981","unstructured":"Kumar A (1981) Diagnostic advantages of the Torok monothermal differential caloric test. Laryngoscope 91:1678\u20131694","journal-title":"Laryngoscope"},{"key":"988_CR16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00005537-200401000-00018","volume":"114","author":"Lange","year":"2004","unstructured":"Lange G, Maurer J, Mann W (2004) Long-term results after interval therapy with intratympanic gentamicin for Meniere\u2019s disease. Laryngoscope 114:102\u2013105","journal-title":"Laryngoscope"},{"key":"988_CR17","first-page":"322","volume":"20","author":"Leone","year":"2000","unstructured":"Leone CA, Mosca F, Mincione A (2000) La terapia ablativa con gentamicina nel trattamento della malattia di Meni\u00e8re. Acta Otorhinolaryngol Ital 20:322\u2013329","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"988_CR18","first-page":"35","volume":"29","author":"Longridge","year":"2000","unstructured":"Longridge NS, Mallison AI (2000) Low-dose intratympanic treatment for dizziness in Meniere\u2019s disease. J Otolaryngol 29:35\u201339","journal-title":"J Otolaryngol"},{"key":"988_CR19","unstructured":"Lundquist PG, Wersall J (1967) The ototoxic effect of gentamicin\u2014an electron microscopic study. In: Gentamicin. First International Symposium. Schwabe, Basel, pp 26\u201346"},{"key":"988_CR20","first-page":"671","volume":"Otolaryngol","author":"Magnusson","year":"1991","unstructured":"Magnusson M, Padoan S (1991) Delayed onset of ototoxic effects of gentamicin in treatment of Meniere\u2019s disease. Rationale for extremely low dose therapy. Acta Otolaryngol (Stockh) 111:671\u2013676","journal-title":"Acta"},{"key":"988_CR21","first-page":"209","volume":"20","author":"Minor","year":"1999","unstructured":"Minor LB (1999) Intratympanic gentamicin for control of vertigo in Meniere\u2019s disease: vestibular signs that specify completion of therapy. Am J Otol 20:209\u2013219","journal-title":"Am J Otol"},{"key":"988_CR22","first-page":"95","volume":"21","author":"Nedzelski","year":"1992","unstructured":"Nedzelski JM, Bryce GE, Pfleiderer AG (1992) Treatment of Meniere\u2019s disease with topical gentamicin: a preliminary report. J Otolaryngol 21:95\u2013101","journal-title":"J Otolaryngol"},{"key":"988_CR23","unstructured":"Odkvist LM, Bergholtz LM, Lundgren A (1984) Topical gentamicin treatment for disabling Meniere\u2019s disease. Acta Otolaryngol (Stockh) [Suppl] 412:74\u201376"},{"key":"988_CR24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0196-0709(85)80013-2","volume":"6","author":"Pender","year":"1985","unstructured":"Pender D (1985) Gentamicin tympanoclisis: effects on the vestibulary secretory cells. Am J Otolaryngol 6:358\u2013367","journal-title":"Am J Otolaryngol"},{"key":"988_CR25","first-page":"387","volume":"Otolaryngol","author":"Quaranta","year":"2001","unstructured":"Quaranta A, Scaringi A, Aloisi A, Quaranta N, Salonna I (2001) Intratympanic therapy for Meniere\u2019s disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol (Stockh) 121:387\u2013392","journal-title":"Acta"},{"key":"988_CR26","doi-asserted-by":"crossref","unstructured":"Rudnick MD, Ginsberg IA, Huber PS (1980) Aminoglycoside ototoxicity following middle ear injection. Ann Otol Rhinol Laryngol 89 [Suppl 779]:1\u20139","DOI":"10.1177\/00034894800896S302"},{"key":"988_CR27","unstructured":"Rybak LP (1986) Ototoxic mechanism. Neurobiology of hearing. Raven Press, New York, pp 441\u2013454"},{"key":"988_CR28","unstructured":"Schuknecht HF (1957) Ablation therapy in the management of Meniere\u2019s disease. Acta Otolaryngol (Stockh) [Suppl] 132:1\u201342"},{"key":"988_CR29","first-page":"172","volume":"Otolaryngol","author":"Stokroos","year":"2004","unstructured":"Stokroos R, Kingma H (2004) Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Meniere\u2019s disease: a prospective, double blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol (Stockh) 124:172\u2013175","journal-title":"Acta"},{"key":"988_CR30","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2165\/00003495-200161080-00005","volume":"61","author":"Thai-Van","year":"2001","unstructured":"Thai-Van H, Bounaix MJ, Fraysse B (2001) Meniere\u2019s disease. Pathophisiology and treatment. Drugs 61:1089\u20131102","journal-title":"Drugs"},{"key":"988_CR31","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1172\/JCI112463","volume":"77","author":"Tran","year":"1986","unstructured":"Tran Ba Huy P, Bernard P, Schacht J (1986) Kinetics of gentamicin uptake and release in the rat: comparison of inner ear tissue and fluids with other organs. J Clin Invest 77:1492\u20131500","journal-title":"J Clin Invest"},{"key":"988_CR32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0378-5955(87)90177-8","volume":"30","author":"Williams","year":"1987","unstructured":"Williams SE, Zenner H, Schacht J (1987) Three molecular steps of aminoglycoside ototoxicity demonstrated in outer hair cells. Hear Res 30:11\u201318","journal-title":"Hear Res"},{"key":"988_CR33","first-page":"435","volume":"19","author":"Youssef","year":"1998","unstructured":"Youssef TF, Poe DS (1998) Intratympanic gentamicin injection for the treatment of the Meniere\u2019s disease. Am J Otol 19:435\u2013442","journal-title":"Am J Otol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-005-0988-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-005-0988-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-005-0988-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T14:00:35Z","timestamp":1559052035000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-005-0988-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,15]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1007\/s00405-005-0988-0","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,15]]}}}